NiveshIQ
Dishman Carbogen Amcis Ltd.
NiveshIQ has detected 5 active signals on DCAL. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeAbout Dishman Carbogen Amcis Ltd.
Dishman Carbogen Amcis Limited (DCAL) is a leading provider of contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide, operating through two main segments: Contract Research and Manufacturing Services and Marketable Molecules. The company's core business involves offering a range of products, including cholesterol and vitamin D analogs, generic active pharmaceutical ingredients, and softgel formulations, among others. With a revenue of ₹2932 Cr and a net income of ₹97 Cr, DCAL has established itself as a significant player in the healthcare sector. Recent developments, such as the company's EPS growth, have made it an interesting case for investors to consider. DCAL's competitive position is further strengthened by its diverse product portfo
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹2,616 Cr +8.40% | ₹2,712 Cr +3.70% | ₹2,932 Cr +8.10% |
| EBITDA Margin | 10.97% | 17.30% | 21.20% |
| Net Profit | ₹3.00 Cr | ₹101.25 Cr +3275.00% | |
| EPS | ₹-9.79 | ₹0.21 | ₹6.22 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Strategic Outlook
- Q1FY27 results: PAT ₹-58 Cr, EPS ₹-3.69. Growth context: PAT QoQ -352.9%.
Net inflows, client activity, yield discipline, and AUM momentum remain the key forward drivers for the next 2–4 quarter...
FY26 (last completed FY): PAT ₹101 Cr, EPS ₹6.22, ROE 1.6%. Year-on-year: PAT YoY +3275.0%....
Everything you unlock with a free account
Frequently Asked Questions
What AI signals does NiveshIQ provide for Dishman Carbogen Amcis Ltd.?
NiveshIQ detects active intelligence signals for Dishman Carbogen Amcis Ltd. (DCAL) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Dishman Carbogen Amcis Ltd.?
Dishman Carbogen Amcis Ltd. operates in the Chemicals sector with a market capitalisation of ₹290,519.1L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.